Webb ML - Search Results

1

Angiotensin-converting enzyme inhibition and angiotensin II subtype-1 receptor blockade during the progression of left ventricular dysfunction: differential effects on myocyte contractile processes.

Spinale FG, Holzgrefe HH, Mukherjee R, Webb ML, Hird RB, Cavallo MJ, Powell JR, Koster WH. Spinale FG, et al. Among authors: webb ml. J Pharmacol Exp Ther. 1997 Dec;283(3):1082-94. J Pharmacol Exp Ther. 1997. PMID: 9399980

2

Exogenous effects and endogenous production of endothelin in cardiac myocytes: potential significance in heart failure.

Thomas PB, Liu EC, Webb ML, Mukherjee R, Hebbar L, Spinale FG. Thomas PB, et al. Among authors: webb ml. Am J Physiol. 1996 Dec;271(6 Pt 2):H2629-37. doi: 10.1152/ajpheart.1996.271.6.H2629. Am J Physiol. 1996. PMID: 8997325

3

The effects of endothelin-A receptor blockade during the progression of pacing-induced congestive heart failure.

Saad D, Mukherjee R, Thomas PB, Iannini JP, Basler CG, Hebbar L, O SJ, Moreland S, Webb ML, Powell JR, Spinale FG. Saad D, et al. Among authors: webb ml. J Am Coll Cardiol. 1998 Nov 15;32(6):1779-86. doi: 10.1016/s0735-1097(98)00439-2. J Am Coll Cardiol. 1998. PMID: 9822109 Free article.

4

Comparison of a novel ETA receptor antagonist and phosphoramidon in renal ischemia.

Bird JE, Webb ML, Wasserman AJ, Liu EC, Giancarli MR, Durham SK. Bird JE, et al. Among authors: webb ml. Pharmacology. 1995 Jan;50(1):9-23. doi: 10.1159/000139262. Pharmacology. 1995. PMID: 7899482

5

BMS-182874 is a selective, nonpeptide endothelin ETA receptor antagonist.

Webb ML, Bird JE, Liu EC, Rose PM, Serafino R, Stein PD, Moreland S. Webb ML, et al. J Pharmacol Exp Ther. 1995 Mar;272(3):1124-34. J Pharmacol Exp Ther. 1995. PMID: 7891325

6

Pharmacological profile of BMS 180,291: a potent, long-acting, orally active thromboxane A2/prostaglandin endoperoxide receptor antagonist.

Ogletree ML, Harris DN, Schumacher WA, Webb ML, Misra RN. Ogletree ML, et al. Among authors: webb ml. J Pharmacol Exp Ther. 1993 Feb;264(2):570-8. J Pharmacol Exp Ther. 1993. PMID: 8437108

7

Binding and function of a potent new thromboxane receptor antagonist, BMS 180,291, in human platelets.

Webb ML, Liu EC, Monshizadegan H, Hedberg A, Misra RN, Goldenberg H, Harris DN. Webb ML, et al. J Pharmacol Exp Ther. 1993 Mar;264(3):1387-94. J Pharmacol Exp Ther. 1993. PMID: 8450473

8

Discovery and characterization of triaminotriazine aniline amides as highly selective p38 kinase inhibitors.

Lin TH, Metzger A, Diller DJ, Desai M, Henderson I, Ahmed G, Kimble EF, Quadros E, Webb ML. Lin TH, et al. Among authors: webb ml. J Pharmacol Exp Ther. 2006 Aug;318(2):495-502. doi: 10.1124/jpet.105.097568. Epub 2006 May 15. J Pharmacol Exp Ther. 2006. PMID: 16702443

9

A role for endothelin ETA receptors in regulation of renal function in spontaneously hypertensive rats.

Bird JE, Webb ML, Giancarli MR, Chao C, Dorso CR, Asaad MM. Bird JE, et al. Among authors: webb ml. Eur J Pharmacol. 1995 Dec 27;294(1):183-9. doi: 10.1016/0014-2999(95)00537-4. Eur J Pharmacol. 1995. PMID: 8788430

10

Cloning and expression of an endothelin receptor subtype B from human prostate that mediates contraction.

Webb ML, Chao CC, Rizzo M, Shapiro RA, Neubauer M, Liu EC, Aversa CR, Brittain RJ, Treiger B. Webb ML, et al. Mol Pharmacol. 1995 Apr;47(4):730-7. Mol Pharmacol. 1995. PMID: 7536888

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters